Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of Pazopanib as Pre-Surgical Therapy in Resectable Stage I NSCLC
2006-000143-26Phase 2Completed
- Sponsor
- GSK
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pazopanib in non-small cell lung cancer (NSCLC), sponsored by GSK. Primary endpoint: Tumor volume response rate. Started May 2006; status: completed.
02
Drugs
pazopanib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2006-000143-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000143-26.